GlaxoSmithKline plc CEDEAR Logo

GlaxoSmithKline plc CEDEAR (GSK)

BCBA

Currency in ARS
20,910.00
+280.00 (+1.36%)

Closed

Aug 21, 2026

Day's Range

20,450.00
20,940.00

52 wk Range

12,975.00
22,760.00

Analyst Ratings - GSK - GlaxoSmithKline plc CEDEAR

Analyst ratings

DateFirmActionRating
Oct 27, 2025JefferiesAssumes coverageHold → Buy
Nov 12, 2024JefferiesDowngradeBuy → Hold
Oct 31, 2024GuggenheimDowngradeBuy → Neutral
Jul 08, 2024UBSDowngradeBuy → Neutral
Mar 04, 2024GuggenheimUpgradeNeutral → Buy
Feb 11, 2022DZ BankDowngradeBuy → Hold
Nov 05, 2021BarclaysUpgradeUnderweight → Equal-Weight
Mar 23, 2021SVB LeerinkDowngradeOutperform → Market Perform
Feb 04, 2021Deutsche BankDowngradeHold → Sell
Jan 15, 2021Deutsche BankInitiates coverageHold
Items per row:

Estimates - GSK - GlaxoSmithKline plc CEDEAR

Estimate momentum

Current quarter · How the consensus estimate has moved over the last 90 days.

Revised last month0/0

EPS estimates

PeriodAnalystsLowAverageHighYear ago
Current quarter-----
Next quarter-----
Current year-----
Next year-----

Earnings History - GSK - GlaxoSmithKline plc CEDEAR

Estimate surprises

DateTimeEPS EstimateEPS ActualDifferenceSurprise PRC
2026-06-17-3.123.16+0.04‪+1.28%‬
2026-04-15-0.500.53+0.03‪+6.00%‬
2025-11-07-1.771.67-0.10‪-5.65%‬

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.